admin

PARIS, March 31, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) in combination with carfilzomib and dexamethasone (Kd), for the treatment of adult patients with relapsed or refractory multiple myeloma (RRMM) who have received one to three prior lines of therapy. “In the Phase 3 IKEMA study, the addition
0 Comments
Primary care physicians (PCPs) can be key players in the movement to building confidence in the COVID-19 vaccine, according to panelists at a Bipartisan Policy Center (BPC) and GTMRx Institute webinar. Since last November, CVS Caremark has surveyed thousands of Americans about their intentions regarding the COVID vaccine, explained Sree Chaguturu, MD, CVS Caremark chief
0 Comments
Why is Ho’oponopono powerful? Throughout human history, we have been divided by distance, language, cultural and religious beliefs, class, and economic hierarchy. Whenever someone comes up with a perspective there seems to always be someone else there with an opposing opinion. To me, the power of Ho’oponopono comes, in large part, from the fact that
0 Comments
Psychosexual therapist, presenter and author Lohani Noor joins Happiful’s podcast to talk about sexual intimacy and the impact the past year has had on our closest relationships Lohani Noor is one of Happiful’s favourite people to talk to when it comes to the subject of sexual intimacy. We recognise that it’s not always an easy
0 Comments
In the days before baby monitors,  bedtime and naptime were (and still are) deserved respites for parents. But they didn’t necessarily relax during these periods. Leaving baby alone on the second floor of the house or way down a hall usually prompted a few visits to the nursery to see if all was well. But
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Adults under 30 years of age will be offered an alternative vaccine to the AstraZeneca/Oxford vaccine as a preference and where this is available, according to Professor Jonathan Van-Tam, England’s deputy chief medical officer, speaking at today’s update by the United
0 Comments
In a large cohort of insured working adults with severe obesity and nonalcoholic fatty liver disease (NAFLD), among those who underwent bariatric surgery, the rate of incident cancer was lower during a 10-month median follow-up period. The rate was especially lower with regard to obesity-related cancers. The risk reduction was greater among patients with cirrhosis. Among
0 Comments
Amlodipine, sold under the brand name Norvasc among others, belongs to a class of medications called calcium channel blockers.1 Amlodipine is commonly prescribed to treat hypertension and a variety of conditions related to the cardiovascular system. How does amlodipine work, what is it used for, and what are the common side effects? Amlodipine, which is available
0 Comments
NEW YORK & INDIANAPOLIS–(BUSINESS WIRE) March 25, 2021 — Pfizer Inc. (NYSE:PFE) and Eli Lilly and Company (NYSE:LLY) today announced the outcome of the U.S. Food and Drug Administration (FDA) Joint Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee on tanezumab. There was a single voting question focused on whether the proposed
0 Comments
April 2, 2021 Audience: Consumer, Patient, Health Professional, Pharmacy April 02, 2021 — Libertyville, IL, A-S Medication Solutions, LLM (ASM) is voluntarily recalling 198,350 bottles of Acetaminophen Extra Strength 500 mg Tablets, 100 ct. bottles (NDC# 50090-5350-0) contained in Health Essentials Kits distributed by Humana to its members. See the photo below. This recall is
0 Comments
A graded dosing protocol allowed two patients with hypersensitivity reactions to the first dose of Moderna’s COVID-19 vaccine to receive their second doses safely, researchers said. The patients — one with an immediate hypersensitivity reaction managed on site and one needing emergency department transport — got divided second doses, reported S. Shahzad Mustafa, MD, of
0 Comments
“What do you want to be when you grow up?” This question always confounded me when people would ask me this as a child. What is this “growing up” you speak of? And why do I have to be something? I’m so content with my LEGOs, books, and video games. I was born in the
0 Comments
Katie spent much of her life feeling as though she didn’t fit anywhere. Years of bullying, loneliness, and anxiety eventually led her to self-harm and suicide attempts. However, it was in the dark world of monsters and horror that she found comfort, an understanding of herself, and a place to belong Have you found that
0 Comments
So You Want to Become a Military Doctor. Here’s how you can decide if military medicine is a good field for you, how to become a military doc, and some of the lesser known truths of being one. 💌 Sign up for my weekly newsletter – https://medschoolinsiders.com/newsletter 🌍 Website & blog – https://medschoolinsiders.com 📸 Instagram
0 Comments
New mental health “hubs” will be set up by next April, offering physical health checks and psychological therapy in one place Becoming a parent brings with it a whole host of changes, both mentally and physically. Everyone experiences these changes differently and some need more support than others, but this support hasn’t always been easy
0 Comments
Cardiovascular and metabolic risk factors are increased among transgender youths compared with youths who are not transgender. Elevations in lipid levels and body mass index (BMI) also occur in adult transgender patients, new research shows. “This is the first study of its size in the United States of which we are aware that looks at
0 Comments
In a methodologically ‘state-of-the-art’ approach, US researchers have developed a protein-based nanoparticle vaccine against coronavirus disease (COVID-19), with a swift generation of antibodies and the potential to protect individuals who cannot receive other COVID-19 vaccines for medical reasons. The research is posted to the bioRxiv* preprint server. Vaccines currently in use against the severe acute
0 Comments
FDA Approves Qelbree (viloxazine) for the Treatment of ADHD ROCKVILLE, Md., April 02, 2021 (GLOBE NEWSWIRE) – Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that the U.S. Food and Drug Administration (FDA) approved Qelbree (viloxazine extended-release capsules) for the treatment of attention-deficit hyperactivity
0 Comments
Rates of prolonged visits for pediatric mental health emergency department (ED) visits increased over a decade, in contrast to non-mental health visits for which visit times remained stable, according to a study published in the journal Pediatrics. From 2005-2015, rates of ED visits lasting over six hours for children presenting for mental health issues jumped
0 Comments